相关实验视频
Updated: Jul 5, 2025

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.3K
在CD3ε上敲击的小型CAR扩展了TCR功能,在内源TCR信号级联的控制下具有CAR特异性
Katrin Manske1, Lisa Dreßler1, Simon P Fräßle1
1Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Journal of immunological methods
|January 12, 2024
概括
研究人员通过最大限度地降低CAR有效载荷大小,开发了一种新的仿真抗原受体 (CAR) T细胞疗法. 这种方法增强了CAR T细胞的活性,并保留了天然T细胞受体 (TCR) 功能,以改善癌症治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 基因编辑 基因编辑
背景情况:
- 化学抗原受体 (CAR) T细胞治疗是一种有前途的免疫疗法,目前FDA批准的产品依赖于lentiviral基因转移.
- 克里斯普尔/卡斯基因编辑为下一代CAR T细胞提供了潜力,但货物大小限制构成了挑战.
- 正在探索有针对性的整合策略,以克服大小限制并提高CAR T细胞的疗效.
研究的目的:
- 通过有针对性的集成来研究尽量减少CAR T细胞有效载荷大小的可行性.
- 开发一种新的CAR T细胞结构,利用内源性T细胞受体 (TCR) 信号级联.
- 评估小型CAR T细胞设计用于癌症治疗的治疗潜力.
主要方法:
- 通过降低对其抗原结合域的有效载荷来设计第一代CAR T细胞.
- 利用CRISPR/Cas介导的基因传递来针对性地整合CAR结构.
- 在CD3ε促进体的控制下实现了融合,产生了CAR-CD3ε融合蛋白.
主要成果:
- 通过有针对性的整合,成功减少了CAR有效载荷大小.
- 产生了一种CAR-CD3ε融合蛋白,有效地利用内源的TCR信号通路.
- 观察到强大的CAR活性和初级抗原识别功能的保留.
结论:
- 通过将抗原结合域融合到CD3ε来缩小CAR有效载荷是增强CAR T细胞治疗的可行策略.
- 这种方法保持了内源的TCR信号传递和抗原识别,提供了潜在的更安全,更有效的自主CAR T细胞疗法.
- 这种新的CAR T细胞设计对未来在治疗各种疾病中的应用具有前景.
相关概念视频
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Diversity of Antigen Receptors
591
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
591

